Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO‐1 Pathway and Shifting Macrophage PolarizationHongyan Lu, Kehua Jiang|Oxidative Medicine and Cellular Longevity|2021Cited by 37